Role and Professional Experience of Deyan Denev

Deyan Denev holds the position of Executive Director of the Association of Research-Based Pharmaceutical Manufacturers in Bulgaria (ARPharM). The Association represents the research-based pharmaceutical industry in Bulgaria, bringing together 22 international innovative pharmaceutical companies that supply modern medicinal products and enable Bulgarian doctors to apply advanced therapeutic approaches in the treatment of severe, life-threatening, and disabling diseases.

ARPharM advocates the collective position of its members before state institutions and healthcare organisations on issues related to medicine supply, reimbursement of medicinal products with public funds, as well as overall health policy. The organisation’s main mission is to cooperate with health authorities to ensure Bulgarian patients have access to modern, high-quality, and effective pharmaceutical treatment.

Education and Expertise

Deyan Denev is a lawyer with a degree from Sofia University “St. Kliment Ohridski” and an expert in pharmaceutical legislation and medicine policy. As the director of the association, he leads the activities of the research-based pharmaceutical industry on key issues related to medicine policy and regulations, intellectual property, and improving patient access to modern treatment.

Participation in Professional Organisations and Committees

Deyan Denev is a member of the Transparency Commission at the Council of Ministers, where he represents the pharmaceutical industry in Bulgaria. From January 2014 to January 2015, he represented the Confederation of Employers and Industrialists in Bulgaria on the Supervisory Board of the National Health Insurance Fund (NHIF).

Additionally, Deyan Denev is Co-Chair of the Special Working Group for Central and Eastern Europe at the European Federation of Pharmaceutical Industries and Associations (EFPIA). He is also chairs the Management Board of the Bulgarian Medicines Verification Organisation (BgMVO).